Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Immunology : an introductory textbook / / edited by Anil K. Sharma
| Immunology : an introductory textbook / / edited by Anil K. Sharma |
| Pubbl/distr/stampa | Singapore : , : Pan Stanford Publishing, , 2019 |
| Descrizione fisica | 1 online resource (261 pages) |
| Disciplina | 616.079072 |
| Soggetto topico |
Immunology - Research
Immunology - Technique |
| ISBN |
1-351-36694-7
1-351-36695-5 1-315-15063-8 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Half Title; Title Page; Copyright Page; Table of Contents; Preface; 1: Introduction to lmmunology; 1.1 Historical Attributes; 1.2 lmmunological Responses and Effectors; 1.2.1 lnnate and Adaptive lmmunity; 1.2.1.1 lnnate immunity; 1.2.1.2 Adaptive immunity; 1.3 Summary; 2: lmmunity; 2.1 Basic Concept of lmmunity; 2.2 Historical Background of Immune Responses; 2.3 Cell-Mediated Immune Responses; 2.4 Processing of Endogenous Antigens: Cytosolic Pathway; 2.5 Processing of Endogenous Antigens: Endocytic Pathway; 2.6 Humoral Immunity; 2.7 Activation of B-Cells
2.8 Humoral Response to T-Dependent Antigens2.9 Humoral Response to T-lndependent Antigens; 3: Proteins of the Immune System; 3.1 Antimicrobial Peptide; 3.2 Pattern Recognition Receptor; 3.3 Toll-Like Receptors; 3.4 NOD Protein; 3.5 Acute Phase Proteins; 3.6 Interferon; 3.7 Complement System; 3.7.1 Function of Complement System; 3.7.2 Complement Nomenclature; 3.8 Activation of Complement Pathways; 3.9 Classical Pathway of the Complement System; 3.10 Lectin Pathway; 3.11 Alternative Pathway; 3.12 Small Fragments of the Complement Protein Initiates Local Inflammatory Response 3.13 Membrane Attack Complex (MAC) or Lytic Pathway3.14 Regulation of Complement Protein; 3.15 Summary; 4: Major Histocompatibility Complex (MHC): Recent Trends and Relevance from lmmunological Perspective; 4.1 Introduction; 4.2 Nomenclature of HLA Antigens; 4.3 Frequency of Different HLA Alleles; 4.4 Molecular and Genetics Basis of MHC Polymorphisms; 4.4.1 Inheritance; 4.4.2 Expression; 4.5 MHC Molecules: Structure and Genetics; 4.5.1 MHC Class I vs. MHC Class Il; 4.5.1.1 MHC Class I; 4.5.1.2 MHC Class Il; 4.6 Role of MHC in Immune Response; 4.6.1 The Mixed Lymphocyte Reaction 4.6.2 Antigen Processing and Presentation4.6.3 Sorne Points about MHC Class I and Class Il /TCR; 4.7 Antigen Processing and Presentation; 4.8 Langerhans Cells as APC; 4.9 Antigen Processing and Presentation by Class Il (Exogenous/Endocytic) Pathway; 4.10 Antigen Processing and Presentation by Class I (Endogenous/Cytosolic) Pathway; 4.11 Significance of MHC-Peptide Presentation; 4.12 Clonal Selection of T-cells; 4.13 Generation of Cytotoxic T-Cells; 4.14 Immune Response Genes; 4.15 Complement Factor Genes; 4.16 Nonimmunologic Functions of MHC Genes 4.17 Disease and the Major Histocompatibility Complex5: Immune System of the Brain; 5.1 Introduction; 5.2 Microglia; 5.3 Astrocytes; 5.4 Toll-Like Receptors; 5.5 Pro-lnflammatory Cytokines; 5.6 Summary; 6: An Overview of lmmunodeficiency Disorders; 6.1 Introduction; 6.2 Primary lmmunodeficiency Diseases; 6.3 Classification of Primary lmmunodeficiency; 6.3.1 Severe Combined lmmunodeficiency; 6.3.1.1 X-linked recessive severe combined immunodeficiency; 6.3.1.2 Adenosine deaminase deficiency; 6.3.2 Well-Defined Syndromes with lmmunodeficiency |
| Record Nr. | UNINA-9910793456503321 |
| Singapore : , : Pan Stanford Publishing, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Immunology : an introductory textbook / / edited by Anil K. Sharma
| Immunology : an introductory textbook / / edited by Anil K. Sharma |
| Pubbl/distr/stampa | Singapore : , : Pan Stanford Publishing, , 2019 |
| Descrizione fisica | 1 online resource (261 pages) |
| Disciplina | 616.079072 |
| Soggetto topico |
Immunology - Research
Immunology - Technique |
| ISBN |
1-351-36694-7
1-351-36695-5 1-315-15063-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Half Title; Title Page; Copyright Page; Table of Contents; Preface; 1: Introduction to lmmunology; 1.1 Historical Attributes; 1.2 lmmunological Responses and Effectors; 1.2.1 lnnate and Adaptive lmmunity; 1.2.1.1 lnnate immunity; 1.2.1.2 Adaptive immunity; 1.3 Summary; 2: lmmunity; 2.1 Basic Concept of lmmunity; 2.2 Historical Background of Immune Responses; 2.3 Cell-Mediated Immune Responses; 2.4 Processing of Endogenous Antigens: Cytosolic Pathway; 2.5 Processing of Endogenous Antigens: Endocytic Pathway; 2.6 Humoral Immunity; 2.7 Activation of B-Cells
2.8 Humoral Response to T-Dependent Antigens2.9 Humoral Response to T-lndependent Antigens; 3: Proteins of the Immune System; 3.1 Antimicrobial Peptide; 3.2 Pattern Recognition Receptor; 3.3 Toll-Like Receptors; 3.4 NOD Protein; 3.5 Acute Phase Proteins; 3.6 Interferon; 3.7 Complement System; 3.7.1 Function of Complement System; 3.7.2 Complement Nomenclature; 3.8 Activation of Complement Pathways; 3.9 Classical Pathway of the Complement System; 3.10 Lectin Pathway; 3.11 Alternative Pathway; 3.12 Small Fragments of the Complement Protein Initiates Local Inflammatory Response 3.13 Membrane Attack Complex (MAC) or Lytic Pathway3.14 Regulation of Complement Protein; 3.15 Summary; 4: Major Histocompatibility Complex (MHC): Recent Trends and Relevance from lmmunological Perspective; 4.1 Introduction; 4.2 Nomenclature of HLA Antigens; 4.3 Frequency of Different HLA Alleles; 4.4 Molecular and Genetics Basis of MHC Polymorphisms; 4.4.1 Inheritance; 4.4.2 Expression; 4.5 MHC Molecules: Structure and Genetics; 4.5.1 MHC Class I vs. MHC Class Il; 4.5.1.1 MHC Class I; 4.5.1.2 MHC Class Il; 4.6 Role of MHC in Immune Response; 4.6.1 The Mixed Lymphocyte Reaction 4.6.2 Antigen Processing and Presentation4.6.3 Sorne Points about MHC Class I and Class Il /TCR; 4.7 Antigen Processing and Presentation; 4.8 Langerhans Cells as APC; 4.9 Antigen Processing and Presentation by Class Il (Exogenous/Endocytic) Pathway; 4.10 Antigen Processing and Presentation by Class I (Endogenous/Cytosolic) Pathway; 4.11 Significance of MHC-Peptide Presentation; 4.12 Clonal Selection of T-cells; 4.13 Generation of Cytotoxic T-Cells; 4.14 Immune Response Genes; 4.15 Complement Factor Genes; 4.16 Nonimmunologic Functions of MHC Genes 4.17 Disease and the Major Histocompatibility Complex5: Immune System of the Brain; 5.1 Introduction; 5.2 Microglia; 5.3 Astrocytes; 5.4 Toll-Like Receptors; 5.5 Pro-lnflammatory Cytokines; 5.6 Summary; 6: An Overview of lmmunodeficiency Disorders; 6.1 Introduction; 6.2 Primary lmmunodeficiency Diseases; 6.3 Classification of Primary lmmunodeficiency; 6.3.1 Severe Combined lmmunodeficiency; 6.3.1.1 X-linked recessive severe combined immunodeficiency; 6.3.1.2 Adenosine deaminase deficiency; 6.3.2 Well-Defined Syndromes with lmmunodeficiency |
| Record Nr. | UNINA-9910820026503321 |
| Singapore : , : Pan Stanford Publishing, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
International benchmarking of US immunology research [[electronic resource] /] / Panel on International Benchmarking of US Immunology Research, Committee on Science, Engineering, and Public Policy, National Academy of Sciences, National Academy of Engineering, Institute of Medicine
| International benchmarking of US immunology research [[electronic resource] /] / Panel on International Benchmarking of US Immunology Research, Committee on Science, Engineering, and Public Policy, National Academy of Sciences, National Academy of Engineering, Institute of Medicine |
| Pubbl/distr/stampa | Washington, DC, : National Academy Press, 1999 |
| Descrizione fisica | 1 online resource (60 p.) |
| Disciplina | 616.079072 |
| Soggetto topico |
Immunology - Research
Immunity |
| Soggetto genere / forma | Electronic books. |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""INTERNATIONAL BENCHMARKING OF US IMMUNOLOGY RESEARCH""; ""Copyright""; ""PREFACE""; ""CONTENTS""; ""EXECUTIVE SUMMARY""; ""1 INTRODUCTION""; ""1.1 HOW IMPORTANT IS IT FOR THE UNITED STATES TO LEAD IN IMMUNOLOGY RESEARCH?""; ""1.2 WHAT IS IMMUNOLOGY?""; ""1.3 IMMUNOLOGY AS AN ACADEMIC DISCIPLINE""; ""1.4 WHAT IS THE INTERNATIONAL NATURE OF IMMUNOLOGY?""; ""1.5 WHAT ARE SOME CAVEATS?""; ""1.6 PANEL CHARGE AND RATIONALE""; ""2 BENCHMARKING RESULTS""; ""2.1 METHODS""; ""2.1.1 Reputation Survey""; ""2.1.2 Citation Analysis""; ""2.1.3 Journal Publication Analysis""; ""2.2 RESULTS""
""2.2.1 Reputation Survey""""2.2.2 Citation Analysis""; ""2.2.3 Journal Publication Analysis""; ""2.3 SUMMARY""; ""3 KEY FACTORS""; ""3.1 FUNDING""; ""3.2 HUMAN RESOURCES""; ""3.3 INFRASTRUCTURE""; ""3.4 BIOTECHNOLOGY AND PHARMACEUTICAL FIRMS""; ""3.5 THE CLINICAL TRIAL""; ""4 LIKELY FUTURE POSITION""; ""4.1 FUNDING AND RESOURCE LIMITATIONS""; ""4.2 INCREASED COMPETITION FROM EUROPE AND OTHER COUNTRIES""; ""4.3 CLINICAL IMMUNOLOGY AND THE SHIFT TOWARD HMOS""; ""4.4 TRAINING OF US STUDENTS""; ""5 SUMMARY AND CONCLUSIONS"" ""5.1 THE UNITED STATES IS THE WORLD LEADER IN ALL THE MAJOR SUBFIELDS OF IMMUNOLOGY BUT IS ONLY AMONG THE WORLD LEADERS IN�""""5.2 FLEXIBILITY TO PURSUE ORIGINAL AND INNOVATIVE RESEARCH IDEAS HAS ATTRACTED BOTH DOMESTIC AND INTERNATIONAL HUMAN�""; ""5.3 INDUSTRIAL INTERESTS HAVE FOSTERED MANY STRIKING BREAKTHROUGHS IN IMMUNOLOGY""; ""5.4 A SCARCITY OF LARGE-SCALE CLINICAL TRIALS IN IMMUNOLOGY CAN BE ATTRIBUTED TO SHORTAGES OF FUNDING AND OF QUALIFIED�""; ""5.5 SHIFTING FEDERAL AND INDUSTRY PRIORITIES, A POTENTIAL REDUCTION IN ACCESS TO DOMESTIC AND FOREIGN TALENT, AND THE�"" ""REFERENCES""""APPENDIX PANEL AND STAFF BIOGRAPHICAL INFORMATION""; ""STAFF"" |
| Record Nr. | UNINA-9910451478803321 |
| Washington, DC, : National Academy Press, 1999 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
International benchmarking of US immunology research / / Panel on International Benchmarking of US Immunology Research, Committee on Science, Engineering, and Public Policy, National Academy of Sciences, National Academy of Engineering, Institute of Medicine
| International benchmarking of US immunology research / / Panel on International Benchmarking of US Immunology Research, Committee on Science, Engineering, and Public Policy, National Academy of Sciences, National Academy of Engineering, Institute of Medicine |
| Pubbl/distr/stampa | Washington, DC, : National Academy Press, 1999 |
| Descrizione fisica | 1 online resource (60 pages) : illustrations |
| Disciplina | 616.079072 |
| Soggetto topico |
Immunology - Research
Immunity Immunochemistry Immunogenetics Benchmarking (Management) |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""INTERNATIONAL BENCHMARKING OF US IMMUNOLOGY RESEARCH""; ""Copyright""; ""PREFACE""; ""CONTENTS""; ""EXECUTIVE SUMMARY""; ""1 INTRODUCTION""; ""1.1 HOW IMPORTANT IS IT FOR THE UNITED STATES TO LEAD IN IMMUNOLOGY RESEARCH?""; ""1.2 WHAT IS IMMUNOLOGY?""; ""1.3 IMMUNOLOGY AS AN ACADEMIC DISCIPLINE""; ""1.4 WHAT IS THE INTERNATIONAL NATURE OF IMMUNOLOGY?""; ""1.5 WHAT ARE SOME CAVEATS?""; ""1.6 PANEL CHARGE AND RATIONALE""; ""2 BENCHMARKING RESULTS""; ""2.1 METHODS""; ""2.1.1 Reputation Survey""; ""2.1.2 Citation Analysis""; ""2.1.3 Journal Publication Analysis""; ""2.2 RESULTS""
""2.2.1 Reputation Survey"" ""2.2.2 Citation Analysis""; ""2.2.3 Journal Publication Analysis""; ""2.3 SUMMARY""; ""3 KEY FACTORS""; ""3.1 FUNDING""; ""3.2 HUMAN RESOURCES""; ""3.3 INFRASTRUCTURE""; ""3.4 BIOTECHNOLOGY AND PHARMACEUTICAL FIRMS""; ""3.5 THE CLINICAL TRIAL""; ""4 LIKELY FUTURE POSITION""; ""4.1 FUNDING AND RESOURCE LIMITATIONS""; ""4.2 INCREASED COMPETITION FROM EUROPE AND OTHER COUNTRIES""; ""4.3 CLINICAL IMMUNOLOGY AND THE SHIFT TOWARD HMOS""; ""4.4 TRAINING OF US STUDENTS""; ""5 SUMMARY AND CONCLUSIONS"" ""5.1 THE UNITED STATES IS THE WORLD LEADER IN ALL THE MAJOR SUBFIELDS OF IMMUNOLOGY BUT IS ONLY AMONG THE WORLD LEADERS IN""""5.2 FLEXIBILITY TO PURSUE ORIGINAL AND INNOVATIVE RESEARCH IDEAS HAS ATTRACTED BOTH DOMESTIC AND INTERNATIONAL HUMAN""; ""5.3 INDUSTRIAL INTERESTS HAVE FOSTERED MANY STRIKING BREAKTHROUGHS IN IMMUNOLOGY""; ""5.4 A SCARCITY OF LARGE-SCALE CLINICAL TRIALS IN IMMUNOLOGY CAN BE ATTRIBUTED TO SHORTAGES OF FUNDING AND OF QUALIFIED""; ""5.5 SHIFTING FEDERAL AND INDUSTRY PRIORITIES, A POTENTIAL REDUCTION IN ACCESS TO DOMESTIC AND FOREIGN TALENT, AND THE""; ""REFERENCES""""APPENDIX PANEL AND STAFF BIOGRAPHICAL INFORMATION""; ""STAFF"" |
| Record Nr. | UNINA-9910777423403321 |
| Washington, DC, : National Academy Press, 1999 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
International benchmarking of US immunology research / / Panel on International Benchmarking of US Immunology Research, Committee on Science, Engineering, and Public Policy, National Academy of Sciences, National Academy of Engineering, Institute of Medicine
| International benchmarking of US immunology research / / Panel on International Benchmarking of US Immunology Research, Committee on Science, Engineering, and Public Policy, National Academy of Sciences, National Academy of Engineering, Institute of Medicine |
| Pubbl/distr/stampa | Washington, DC, : National Academy Press, 1999 |
| Descrizione fisica | 1 online resource (60 pages) : illustrations |
| Disciplina | 616.079072 |
| Soggetto topico |
Immunology - Research
Immunity Immunochemistry Immunogenetics Benchmarking (Management) |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""INTERNATIONAL BENCHMARKING OF US IMMUNOLOGY RESEARCH""; ""Copyright""; ""PREFACE""; ""CONTENTS""; ""EXECUTIVE SUMMARY""; ""1 INTRODUCTION""; ""1.1 HOW IMPORTANT IS IT FOR THE UNITED STATES TO LEAD IN IMMUNOLOGY RESEARCH?""; ""1.2 WHAT IS IMMUNOLOGY?""; ""1.3 IMMUNOLOGY AS AN ACADEMIC DISCIPLINE""; ""1.4 WHAT IS THE INTERNATIONAL NATURE OF IMMUNOLOGY?""; ""1.5 WHAT ARE SOME CAVEATS?""; ""1.6 PANEL CHARGE AND RATIONALE""; ""2 BENCHMARKING RESULTS""; ""2.1 METHODS""; ""2.1.1 Reputation Survey""; ""2.1.2 Citation Analysis""; ""2.1.3 Journal Publication Analysis""; ""2.2 RESULTS""
""2.2.1 Reputation Survey"" ""2.2.2 Citation Analysis""; ""2.2.3 Journal Publication Analysis""; ""2.3 SUMMARY""; ""3 KEY FACTORS""; ""3.1 FUNDING""; ""3.2 HUMAN RESOURCES""; ""3.3 INFRASTRUCTURE""; ""3.4 BIOTECHNOLOGY AND PHARMACEUTICAL FIRMS""; ""3.5 THE CLINICAL TRIAL""; ""4 LIKELY FUTURE POSITION""; ""4.1 FUNDING AND RESOURCE LIMITATIONS""; ""4.2 INCREASED COMPETITION FROM EUROPE AND OTHER COUNTRIES""; ""4.3 CLINICAL IMMUNOLOGY AND THE SHIFT TOWARD HMOS""; ""4.4 TRAINING OF US STUDENTS""; ""5 SUMMARY AND CONCLUSIONS"" ""5.1 THE UNITED STATES IS THE WORLD LEADER IN ALL THE MAJOR SUBFIELDS OF IMMUNOLOGY BUT IS ONLY AMONG THE WORLD LEADERS IN""""5.2 FLEXIBILITY TO PURSUE ORIGINAL AND INNOVATIVE RESEARCH IDEAS HAS ATTRACTED BOTH DOMESTIC AND INTERNATIONAL HUMAN""; ""5.3 INDUSTRIAL INTERESTS HAVE FOSTERED MANY STRIKING BREAKTHROUGHS IN IMMUNOLOGY""; ""5.4 A SCARCITY OF LARGE-SCALE CLINICAL TRIALS IN IMMUNOLOGY CAN BE ATTRIBUTED TO SHORTAGES OF FUNDING AND OF QUALIFIED""; ""5.5 SHIFTING FEDERAL AND INDUSTRY PRIORITIES, A POTENTIAL REDUCTION IN ACCESS TO DOMESTIC AND FOREIGN TALENT, AND THE""; ""REFERENCES""""APPENDIX PANEL AND STAFF BIOGRAPHICAL INFORMATION""; ""STAFF"" |
| Record Nr. | UNINA-9910818706103321 |
| Washington, DC, : National Academy Press, 1999 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||